ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
301
66.66895
1
female
1
164
164
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
922,581
null
null
37.75
asian
29.699219
32
0.702881
0.613892
1
0
0
no
null
null
dnr after sadm
162
112
19.5
150
19
40.19531
177.5
2.599609
4.099609
0.899902
148
7.489258
null
null
null
null
null
Coma or Intub
2.265625
302
73.36597
1
male
1
64
64
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
41
536,925
268,835.5
null
44.5
white
34.5
68
0.283997
0.174988
4
1
0
no
null
null
dnr after sadm
64
65
21.199219
140
14
36.5
164
2
4.799805
2.399902
144
7.379883
null
null
null
null
null
null
3.11377
303
37.59299
1
male
0
5
391
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
29,615
15,255.3672
null
10
null
20.898438
20
0.893921
0.855957
3
0
0
no
0.8
0.5
no dnr
5
103
7.299805
120
28
36.5
380
null
null
0.799927
139
7.429688
null
null
null
null
null
null
2.90332
304
61.34399
1
female
0
9
643
Colon Cancer
Cancer
2
11
null
9
30,431
16,560.6875
null
26
hispanic
6.099609
24
0.912964
0.797974
1
1
0
metastatic
0.9
0.7
no dnr
9
140
9.798828
70
26
37.5
380
3.199707
0.899902
0.899902
140
7.379883
null
null
null
1
null
no(M2 and SIP pres)
1.1669
305
65.92499
1
male
0
7
275
Colon Cancer
Cancer
2
16
>$50k
0
6,228
3,760.6777
null
9
asian
8.599609
20
0.901978
0.773926
1
1
0
metastatic
0.5
0.2
no dnr
7
73
5.099609
82
16
37.79688
null
3.799805
0.399963
1
137
null
null
null
null
2
0
no(M2 and SIP pres)
0
306
47.33197
0
female
0
8
1,783
COPD
COPD/CHF/Cirrhosis
2
null
null
0
35,296
15,546.6953
null
10.5
white
31
52
0.823975
0.713989
1
0
0
no
0.5
0.4
no dnr
8
73
12.099609
140
36
36.19531
185.6875
null
null
0.399963
133
7.339844
null
null
null
null
null
null
4.038086
307
32.18298
1
female
0
10
16
CHF
COPD/CHF/Cirrhosis
2
null
null
0
12,924
7,960.1914
null
10.5
white
19.796875
23
0.931885
0.883911
1
0
0
no
null
null
no dnr
10
82
12.199219
80
28
36
242.84375
null
null
1.399902
134
7.519531
null
null
null
null
null
<2 mo. follow-up
2.862305
308
48.04398
1
male
1
49
49
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
null
26
786,088
421,848.5
null
47.5
white
36.398438
61
0.464966
0.345947
6
0
0
no
0.4
0.2
dnr after sadm
47
107
21.5
150
30
37.79688
138
2.699707
16.898438
1.399902
143
7.469727
null
null
null
null
3
<2 mo. follow-up
3
309
71.66296
1
female
1
5
5
Coma
Coma
0
null
null
55
21,598
null
null
18
white
24.597656
16
0.349976
0.276978
1
0
0
no
0.01
0.000001
dnr after sadm
5
113
10.199219
110
20
39.89844
215.53125
null
null
0.899902
127
7.439453
null
null
null
null
null
<2 mo. follow-up
2.276856
310
64.45197
1
male
0
8
59
CHF
COPD/CHF/Cirrhosis
3
null
null
0
30,265
16,595.1406
null
24
white
50.898438
52
0.163971
0.042999
1
0
0
no
0.1
0.001
dnr after sadm
4
45
16.898438
135
36
37.39844
108.15625
3
1.299805
1.699951
126
7.549805
null
null
null
null
2
<2 mo. follow-up
2
311
24.515
0
female
0
19
1,782
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
0
83,772
45,348.7812
null
23.666656
hispanic
30
38
0.810913
0.747925
9
0
0
no
0.5
0.5
no dnr
19
120
5.699219
110
28
37.5
69
null
null
0.899902
140
7.5
null
null
null
null
4
no(M2 and SIP pres)
4
312
74.034
1
female
1
9
9
Colon Cancer
Cancer
1
null
null
9
6,429
4,587.7227
null
7
white
28
25
0.536987
0.213989
1
0
0
metastatic
null
null
dnr after sadm
1
73
18.398438
104
24
36.19531
null
null
3.299805
0.699951
127
null
null
null
null
null
null
<2 mo. follow-up
3.373535
313
72.03296
1
male
1
14
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
94
61,750
30,964.6875
null
25
white
31.796875
39
0.169983
0.085999
1
0
0
no
null
null
dnr after sadm
11
117
15.398438
120
12
37.59375
60
3
0.299988
1.699951
138
7.319336
null
null
null
null
null
<2 mo. follow-up
3.808106
314
68.60797
1
male
0
7
267
CHF
COPD/CHF/Cirrhosis
2
null
null
0
8,303
5,529.5977
null
10
white
16.796875
18
0.882935
0.804932
1
1
0
no
0.8
0.7
no dnr
7
87
null
80
24
36.5
332
null
null
1.799805
142
7.479492
null
null
null
null
null
null
2.932129
315
59.40598
1
male
0
46
1,278
CHF
COPD/CHF/Cirrhosis
2
14
$11-$25k
0
157,585
111,605.25
null
12.25
asian
14.5
19
0.894897
0.823975
9
0
0
no
null
null
no dnr
46
78
7.199219
80
24
37
null
null
0.5
1
132
null
null
null
null
3
1
no(M2 and SIP pres)
1
316
20.312
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
99,728
51,038.1562
null
45.5
white
36.195313
72
0.743896
0.662964
5
0
0
no
0.02
0.02
no dnr
7
117
6.299805
160
26
40.09375
130
2.899902
2.5
3
141
7.439453
null
null
null
null
3
<2 mo. follow-up
3
317
80.19397
1
male
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
61
29,857
15,619.8047
null
17
white
16.699219
25
0.682983
0.589966
1
0
0
no
0.05
0.000125
dnr after sadm
3
98
11.099609
90
32
38.5
355.5
null
null
1.199951
141
7.439453
null
null
null
null
null
<2 mo. follow-up
2.948731
318
42.06699
1
male
1
4
4
MOSF w/Malig
ARF/MOSF
1
18
$11-$25k
0
137,943
71,544.75
null
44
white
46
78
0.067993
0.023998
21
0
0
yes
null
null
no dnr
4
47
2.599609
175
36
39.29688
244.875
3
4.799805
5.399414
135
7.449219
null
null
null
null
null
<2 mo. follow-up
2.229492
319
23.81699
1
male
0
73
144
MOSF w/Malig
ARF/MOSF
1
13
$25-$50k
0
245,347
129,712.875
null
15
black
33.898438
55
0.310974
0.197998
25
0
0
metastatic
null
null
dnr after sadm
3
127
17
140
28
37.89844
53.32812
null
null
1.399902
135
7.429688
null
null
null
0
2
adl>=4 (>=5 if sur)
2
320
65.97095
1
male
0
6
676
CHF
COPD/CHF/Cirrhosis
3
null
null
0
16,273
9,118.7188
null
23
white
21.199219
37
0.807983
0.688965
1
0
0
yes
null
null
no dnr
6
52
8.898438
80
32
36.39844
247.59375
3.599609
1.799805
1.199951
136
7.479492
null
null
null
null
null
null
2.404785
321
67.00098
1
male
0
5
11
CHF
COPD/CHF/Cirrhosis
1
12
null
0
15,242
8,664.9688
null
12
white
24.597656
31
0.796997
0.67395
1
0
0
no
0.75
0.6
no dnr
5
42
7.799805
85
20
36.89844
null
3.599609
0.199982
1.399902
138
null
null
null
null
null
null
<2 mo. follow-up
2.139648
322
58.09698
0
male
0
21
1,775
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
$25-$50k
0
150,445
80,889.1875
null
31.333328
hispanic
22.699219
38
0.844971
0.791992
1
1
0
no
null
null
no dnr
21
57
16.597656
120
10
38.29688
192
3.199707
0.5
1.099854
137
7.549805
null
null
null
null
null
no(M2 and SIP pres)
2.317871
323
34.99799
1
female
0
15
455
Coma
Coma
0
18
>$50k
44
8,265
36,901.7812
null
12.666664
white
20.398438
14
0.764893
0.720947
4
0
0
no
0.5
0.2
no dnr
15
103
10.099609
115
20
37.39844
330
null
null
0.699951
134
7.479492
null
null
null
null
1
adl>=4 (>=5 if sur)
1
324
65.96295
1
male
0
55
1,760
ARF/MOSF w/Sepsis
ARF/MOSF
0
4
null
0
181,645
100,455.625
null
21.75
hispanic
21.5
21
0.824951
0.765991
2
0
0
no
0.7
0.6
no dnr
55
80
15.099609
120
30
39
340
3.099609
0.699951
0.899902
142
7.5
null
null
null
null
null
no(M2 and SIP pres)
2.097168
325
43.85999
0
female
0
43
1,773
Cirrhosis
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
186,293
104,734
null
17.25
hispanic
37.898438
63
0.539917
0.340942
1
0
0
no
0.5
0.3
no dnr
43
46
3.5
80
20
37.19531
300
2.399902
38.398438
1.899902
138
7.469727
null
null
null
7
3
null
3
326
29.769
0
male
0
34
1,772
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
181,539
97,215.5625
null
30.5
asian
26
34
0.859985
0.810913
4
0
0
no
null
null
no dnr
34
110
16
120
30
37.69531
397.5
2
4.299805
0.699951
135
7.459961
null
null
null
null
null
null
2.126465
327
52.71997
1
female
1
9
9
Cirrhosis
COPD/CHF/Cirrhosis
3
20
$11-$25k
26
45,273
24,780.7969
null
23.5
white
20.699219
40
0.689941
0.523926
7
0
0
no
0.01
0.000001
dnr after sadm
4
97
9.5
75
18
36.39844
290.4375
null
2
2.5
137
7.429688
null
null
null
null
null
<2 mo. follow-up
3.087891
328
26.24799
1
male
1
4
4
MOSF w/Malig
ARF/MOSF
1
null
null
100
260,829
118,488.25
null
40
white
54.5
117
0
0
47
0
0
yes
null
null
dnr after sadm
3
35
0.049995
40
52
36.69531
206
1.699951
3.799805
1.899902
138
7.219727
null
null
null
null
null
<2 mo. follow-up
3.091797
329
66.75397
1
male
0
46
69
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
306,038
165,393.375
null
33.5
white
28.5
37
0.659912
0.562988
8
0
0
no
null
null
no dnr
46
67
24.097656
120
22
37
106.65625
null
null
1.299805
139
7.509766
null
null
null
null
null
null
2.439941
330
53.125
1
male
0
14
139
Lung Cancer
Cancer
1
8
$11-$25k
0
13,872
7,457.1602
null
5.666664
white
13.298828
13
0.796997
0.56897
1
0
0
metastatic
null
null
no dnr
14
70
9.199219
72
18
36.79688
376.1875
null
0.199982
1
136
7.459961
null
null
null
0
null
null
0.4948
331
70.74097
1
male
0
14
117
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
>$50k
0
72,222
38,194.5
null
37.666657
white
27.398438
49
0.603882
0.496948
6
0
0
yes
0.7
0.5
no dnr
14
77
23
115
28
39
120.40625
2.799805
0.099991
1.199951
135
7.5
null
null
null
null
null
no(M2 and SIP pres)
2.428223
332
54.67798
1
male
0
12
37
CHF
COPD/CHF/Cirrhosis
2
14
null
0
38,322
22,746.25
null
17.5
white
24.898438
40
0.80188
0.680908
6
0
0
no
null
null
no dnr
12
58
null
65
18
36.09375
null
2.5
1.799805
1.299805
145
7.5
null
null
null
3
null
<2 mo. follow-up
2.511099
333
81.45398
1
male
0
30
163
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
92,518
46,889.4062
null
21.75
white
16.398438
42
0.823975
0.764893
5
0
0
no
0.4
0.3
no dnr
30
60
8.398438
75
40
38.89844
391
3
null
1.099854
132
7.529297
null
null
null
null
null
null
2.491211
334
58.27499
1
female
0
40
607
COPD
COPD/CHF/Cirrhosis
1
null
null
0
161,257
74,216.125
null
25.25
black
30.296875
30
0.766968
0.628906
1
0
0
no
0.2
0.15
no dnr
40
77
16.597656
115
12
37.29688
68
3.399902
null
0.899902
144
7.299805
null
null
null
null
6
null
6
335
36.96899
1
female
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
85,027
46,872.9375
null
37
other
48.59375
73
0.228973
0.128998
22
0
0
no
null
null
dnr after sadm
1
111
21.699219
120
70
39.89844
null
4.5
54.296875
5.699219
138
null
null
null
null
null
null
<2 mo. follow-up
2.412109
336
44.47897
0
male
0
8
1,767
Cirrhosis
COPD/CHF/Cirrhosis
1
16
$25-$50k
0
12,696
8,186.1445
null
5
white
21.5
35
0.846924
0.747925
1
0
0
no
0.5
0.5
no dnr
8
100
4.699219
82
18
36.79688
null
2.299805
14.199219
0.799927
137
null
null
null
null
0
0
no(M2 and SIP pres)
0
337
79.98096
0
male
0
13
1,768
Colon Cancer
Cancer
1
16
>$50k
0
42,514
27,452.6562
null
16
white
1.899902
20
0.932983
0.841919
1
0
0
metastatic
0.9
0.75
no dnr
13
115
4.199219
70
22
38.39844
null
3.099609
1.599854
1
142
null
null
null
null
null
0
null
0
338
82.245
1
female
1
10
10
Coma
Coma
0
null
null
61
73,656
39,791
null
34
white
13.699219
19
0.468994
0.395996
4
0
0
no
null
null
dnr after sadm
3
123
null
75
9
36.69531
295
null
null
1.199951
140
7.479492
null
null
null
null
null
<2 mo. follow-up
2.355957
339
38.49698
0
male
0
62
1,766
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
>$50k
26
463,001
269,057
null
26.5
white
26.898438
35
0.736938
0.654907
8
0
0
no
0.8
0.75
no dnr
62
73
10.099609
130
18
38.59375
237.5
3.099609
13.798828
1.099854
145
7.529297
null
null
null
null
0
no(M2 and SIP pres)
0
340
59.37598
1
male
0
19
110
MOSF w/Malig
ARF/MOSF
2
12
under $11k
0
64,372
33,652.5
null
20
black
28
53
0.593994
0.484985
2
1
0
yes
0.5
0.3
no dnr
19
70
0.699951
120
32
37
396.625
2.099609
0.699951
0.899902
138
7.419922
null
null
null
0
0
null
0
341
58.44998
1
male
0
20
33
CHF
COPD/CHF/Cirrhosis
2
20
under $11k
0
30,148
18,298.875
null
7
white
19.296875
29
0.885986
0.80896
1
0
0
no
0.99
0.95
no dnr
20
85
6.199219
90
28
37
403.3125
null
null
1.699951
133
7.5
null
null
null
0
null
<2 mo. follow-up
0.4948
342
83.30194
1
male
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
under $11k
37
49,455
23,976.9219
null
23.5
white
16.097656
42
0.7229
0.637939
4
1
0
no
0.5
0.3
dnr after sadm
9
130
11.898438
80
10
38.5
242.84375
null
null
1
138
7.509766
null
null
null
null
null
<2 mo. follow-up
3.564453
343
43.995
0
female
0
50
1,760
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$11-$25k
26
260,514
173,060.625
null
23.5
white
27.5
33
0.599976
0.41095
9
0
0
no
0.7
0.6
no dnr
50
80
20.898438
130
20
36.29688
485
2.799805
3
1.899902
136
7.459961
null
null
null
0
1
no(M2 and SIP pres)
1
344
50.09698
1
male
0
15
376
MOSF w/Malig
ARF/MOSF
1
12
null
0
29,840
16,369.5781
null
14.333328
other
15.099609
5
0.850952
0.799927
1
0
0
yes
0.8
0.7
no dnr
15
97
11.099609
80
16
37.39844
419
null
0.699951
1.199951
136
7.449219
null
null
null
0
1
null
1
345
80.18896
1
male
1
40
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
19
>$50k
0
257,589
125,511.5
null
25
white
22.597656
37
0.737915
0.656982
4
0
0
no
0.4
0.2
dnr after sadm
39
133
10.199219
120
36
38.69531
204.4375
null
0.5
1.099854
147
7.469727
null
null
null
null
2
<2 mo. follow-up
2
346
40.20499
1
male
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
44
151,181
74,438.9375
null
47
white
40.5
77
0.173981
0.088989
28
0
0
yes
null
null
dnr after sadm
5
52
6.5
150
35
36.79688
122
2.699707
10.599609
1.199951
143
7.349609
null
null
null
null
null
<2 mo. follow-up
3.010742
347
57.01797
1
female
0
5
1,462
CHF
COPD/CHF/Cirrhosis
2
null
null
0
12,504
7,491.3047
null
9
white
9.599609
13
0.947998
0.910889
1
0
0
no
0.8
0.7
no dnr
5
93
12.199219
88
18
37.19531
423.75
4.699219
0.599976
0.899902
133
7.419922
null
null
null
null
null
null
2.463379
348
38.90799
1
female
0
12
1,480
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
null
0
48,336
23,679.7969
null
19.5
white
34.398438
49
0.7229
0.637939
2
0
0
no
0.9
0.9
no dnr
12
107
18.699219
120
28
37.5
280
null
null
4.299805
125
7.289062
null
null
null
null
3
null
3
349
75.54297
1
male
0
11
484
Colon Cancer
Cancer
1
14
$25-$50k
0
18,233
11,379.5781
null
11.5
white
16.796875
11
0.79895
0.573975
1
0
0
metastatic
0.95
0.8
no dnr
11
93
13.898438
84
20
36.19531
null
null
1.199951
1
136
null
null
null
null
2
0
no(M2 and SIP pres)
0
350
34.80899
1
female
1
9
9
MOSF w/Malig
ARF/MOSF
1
null
null
26
71,315
32,862.0938
null
41
white
46.796875
76
0.026997
0.007
1
0
0
metastatic
null
null
dnr after sadm
5
62
0.699951
135
60
38.5
82
2.599609
6.099609
0.5
141
7.40918
null
null
null
null
null
<2 mo. follow-up
3.083496
351
73.72998
1
male
0
15
879
Colon Cancer
Cancer
1
null
null
0
41,836
24,937.7812
null
11.333328
white
5.699219
20
0.914917
0.80188
1
0
0
metastatic
null
null
no dnr
15
127
5.299805
88
18
36.79688
null
4.299805
1.699951
1.099854
141
null
null
null
null
null
null
null
2.167481
352
42.543
1
male
1
12
12
MOSF w/Malig
ARF/MOSF
1
null
null
26
217,970
106,592.312
null
31
white
39.5
65
0.195984
0.103989
1
0
0
yes
null
null
dnr after sadm
8
50
1.099854
140
30
38.5
396.625
null
null
6.699219
137
7.429688
null
null
null
null
null
<2 mo. follow-up
2.62793
353
68.70099
1
male
0
4
100
Lung Cancer
Cancer
1
null
null
0
8,570
4,938.3711
null
11
white
14.398438
20
0.747925
0.487
1
0
0
metastatic
null
null
no dnr
4
121
4.199219
74
8
37.79688
null
null
null
1
137
null
null
null
null
null
null
null
2.243652
354
73.56299
1
male
1
21
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
192,983
104,663.5
null
25
white
35.695313
62
0.199982
0.106995
10
0
0
yes
0.2
0.008
dnr after sadm
20
133
28.597656
140
39
38.89844
61
null
null
0.799927
132
7.399414
null
null
null
null
null
<2 mo. follow-up
2.908203
355
69.10297
1
female
0
12
1,479
Colon Cancer
Cancer
1
null
null
0
39,080
21,387.7969
null
21
white
12.5
29
0.863892
0.695923
1
0
0
metastatic
null
null
no dnr
12
97
10.699219
115
28
37.29688
null
3
3.899902
0.899902
145
null
null
null
null
null
null
null
2.443848
356
67.41095
1
male
1
4
4
Coma
Coma
1
null
null
100
19,247
10,152.1172
null
32
white
50.695313
73
0
0
1
0
0
no
null
null
dnr after sadm
4
35
13
140
10
41
171.40625
null
null
4.299805
151
7.509766
null
null
null
null
null
<2 mo. follow-up
2.92334
357
79.72095
1
male
1
7
7
CHF
COPD/CHF/Cirrhosis
1
18
>$50k
0
23,327
12,108.2656
null
24
asian
47.59375
54
0.144989
0.033997
1
0
0
no
null
null
dnr after sadm
2
33
8.099609
100
16
36.19531
null
2.899902
null
5.5
129
null
null
null
null
null
4
<2 mo. follow-up
4
358
48.35898
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
>$50k
0
60,676
31,216.8438
null
36.5
hispanic
34.296875
22
0.654907
0.555908
4
0
0
no
0.05
0.000125
dnr after sadm
3
87
3.699707
125
17
36.59375
90.65625
null
null
0.599976
143
7.439453
null
null
null
null
0
<2 mo. follow-up
0
359
60.67398
1
male
1
94
94
CHF
COPD/CHF/Cirrhosis
2
12
>$50k
0
481,475
247,740.75
null
31
white
35.796875
59
0.571899
0.377991
3
1
0
no
null
null
dnr after sadm
72
77
9.298828
100
36
36.59375
127.5
null
null
2.599609
125
7.529297
null
null
null
null
3
adl>=4 (>=5 if sur)
3
360
58.31897
1
female
0
5
562
Cirrhosis
COPD/CHF/Cirrhosis
2
null
null
0
5,877
3,397.6699
null
7
hispanic
16.898438
21
0.840942
0.738892
1
0
0
no
0.7
0.5
no dnr
5
87
4.899414
80
20
37.19531
null
2.199707
4.799805
1
135
null
null
null
null
null
null
null
3.124512
361
59.88498
0
male
0
11
1,742
CHF
COPD/CHF/Cirrhosis
1
14
$25-$50k
0
25,441
15,499.7812
null
19
white
13.898438
24
0.921997
0.86792
1
0
0
no
null
null
no dnr
11
67
9.298828
110
18
36.79688
null
4.199219
0.399963
1.399902
140
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
362
64.02698
1
male
0
4
285
CHF
COPD/CHF/Cirrhosis
1
12
null
0
11,926
6,952.0156
null
12
white
8.099609
22
0.945923
0.907959
1
0
0
no
null
null
no dnr
4
62
5.399414
70
18
36.5
252.375
4.599609
1.199951
1.099854
136
7.429688
null
null
null
null
null
null
1.665527
363
34.461
1
female
1
3
3
MOSF w/Malig
ARF/MOSF
1
null
null
0
193,371
93,435.3125
null
33
white
57.398438
70
0.001
0
35
0
0
yes
null
null
dnr after sadm
3
33
1.099854
130
35
35.89844
80
2.5
0.899902
1.299805
141
7.369141
null
null
null
null
null
<2 mo. follow-up
1.951172
364
47.33499
0
female
0
26
1,740
Colon Cancer
Cancer
1
null
null
0
53,037
29,296.4375
null
13
white
16.199219
18
0.855957
0.680908
1
0
0
metastatic
null
null
no dnr
26
93
10
100
20
38.59375
null
4
6.199219
0.699951
140
null
null
null
null
null
null
null
2.608398
365
47.77798
0
female
0
7
1,739
Cirrhosis
COPD/CHF/Cirrhosis
1
null
null
0
14,867
null
null
5.5
other
19.199219
30
0.858887
0.766968
1
0
0
no
null
null
no dnr
7
91
5.599609
76
20
37
null
1.899902
5.299805
0.699951
134
null
null
null
null
null
null
null
2.130371
366
49.28998
1
male
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
0
73,143
38,012.75
null
60
white
57.5
103
0.090988
0.035995
1
0
0
no
0.5
0.5
no dnr
6
47
2.399902
160
40
34
85
null
null
3
139
7.069336
null
null
null
null
null
<2 mo. follow-up
2.186035
367
51.573
1
female
1
24
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
121,630
59,514.5625
null
35.666657
white
29.699219
32
0.537964
0.42395
1
0
0
metastatic
null
null
dnr after sadm
22
98
10.099609
85
28
37.19531
44.4375
3.399902
1.899902
1.299805
133
7.40918
null
null
null
null
null
<2 mo. follow-up
3.379883
368
73.90295
0
male
0
4
1,736
CHF
COPD/CHF/Cirrhosis
2
16
null
0
6,676
4,164.0781
null
11
white
19.199219
22
0.843994
0.743896
1
0
0
no
null
null
no dnr
4
100
14.898438
100
20
36.79688
null
null
null
1.5
137
null
null
null
null
null
null
null
2.252441
369
71.28497
0
male
0
7
1,736
Lung Cancer
Cancer
2
null
null
0
16,142
10,552.0469
null
7
white
16
17
0.713989
0.432983
1
1
0
metastatic
1
0.95
no dnr
7
95
16
70
22
37.5
495.1875
null
null
1.399902
137
7.40918
null
null
null
null
null
null
2.53418
370
55.29898
0
female
0
11
1,735
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
85,170
43,481.7812
null
23
white
21.898438
31
0.825928
0.767944
7
0
0
no
null
null
no dnr
11
83
8.099609
150
32
38.69531
350
null
null
0.899902
130
7.489258
null
null
null
null
null
null
2.897461
371
52.68997
1
male
0
8
353
MOSF w/Malig
ARF/MOSF
1
null
null
26
50,315
27,577.9062
null
13
white
22.699219
28
0.496948
0.378967
6
0
0
metastatic
null
null
no dnr
8
125
15.599609
118
36
37
310
null
null
0.899902
141
7.469727
null
null
null
null
null
null
3.729004
372
81.38794
1
male
1
9
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
207,883
108,700.562
null
42.5
white
26.296875
58
0.483948
0.365967
21
0
0
no
null
null
dnr after sadm
9
63
17.5
70
37
39
285
2.199707
3.199707
4.199219
138
7.449219
null
null
null
null
null
<2 mo. follow-up
3.170898
373
49.29999
1
male
0
29
160
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
0
241,565
129,540.125
null
27.5
white
32.898438
54
0.591919
0.40094
2
0
0
no
0.1
0.001
no dnr
29
87
5.799805
110
16
35.19531
194.28125
2.199707
4
3.099609
148
7.439453
null
null
null
null
null
null
3.924316
374
64.69299
1
male
0
9
523
Colon Cancer
Cancer
1
12
$25-$50k
26
24,410
13,153.6484
null
14
white
7.199219
21
0.876953
0.721924
1
0
0
metastatic
0.9
0.75
no dnr
9
67
9.898438
110
12
37.5
215
4.5
0.799927
1.099854
135
7.449219
null
null
null
0
null
null
0.4948
375
61.67798
1
male
0
9
926
Colon Cancer
Cancer
1
12
>$50k
0
18,565
11,830.1406
null
9.5
white
15.298828
16
0.843994
0.655884
1
0
0
metastatic
0.9
0.8
no dnr
9
95
11.798828
88
20
37
null
null
0.599976
1.299805
139
null
null
null
null
null
null
no(M2 and SIP pres)
2.569336
376
64.25195
1
male
0
4
1,049
CHF
COPD/CHF/Cirrhosis
2
6
null
0
7,339
4,110.2852
null
6
white
20
32
0.863892
0.773926
1
0
0
no
null
null
no dnr
4
73
3.899902
110
24
36.39844
256.625
null
null
1.5
136
7.339844
null
null
null
null
null
no(M2 and SIP pres)
2.195801
377
56.95798
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
26
80,188
43,882.9062
null
37.5
other
42.09375
59
0.227997
0.128998
7
0
0
no
null
null
dnr after sadm
7
68
17.5
125
32
36.39844
193.875
null
35
9.099609
146
7.479492
null
null
null
null
null
<2 mo. follow-up
2.54541
378
29.71399
1
male
1
7
7
MOSF w/Malig
ARF/MOSF
2
null
null
0
55,429
31,358.9688
null
38
other
31.097656
30
0.563965
0.452942
2
0
0
yes
null
null
dnr after sadm
7
120
2.699707
55
14
36.09375
190
null
null
1.5
128
7.449219
null
null
null
null
null
<2 mo. follow-up
2.369141
379
35.56998
1
female
0
33
66
MOSF w/Malig
ARF/MOSF
1
19
>$50k
0
141,926
69,217.8125
null
21
black
31.199219
46
0.491943
0.373962
8
0
0
yes
null
null
no dnr
33
113
0.049995
120
28
37.59375
419
2.5
1.099854
0.699951
133
7.459961
null
null
null
5
6
null
6
380
38.42297
1
male
0
10
520
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
36,468
21,043.3125
null
10
black
22.199219
38
0.886963
0.846924
2
1
0
no
null
null
no dnr
10
114
21
98
20
38
null
null
null
10.5
131
null
null
null
null
null
null
null
3.471191
381
62.53497
1
male
0
24
149
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
41
188,728
91,829.375
null
29.666656
white
30.5
29
0.419983
0.300964
17
0
0
no
0.5
0.4
dnr after sadm
1
88
3.699707
130
24
39.5
140
null
null
1.199951
148
7.5
null
null
null
null
null
null
2.736328
382
76.49597
1
male
1
5
5
Lung Cancer
Cancer
1
null
null
26
7,422
4,047.9668
null
11
white
22.5
51
0.416992
0.113998
1
0
0
metastatic
0.2
0.1
dnr after sadm
2
110
13.898438
72
26
36.19531
209.0625
null
0.399963
2
146
7.40918
null
null
null
null
null
<2 mo. follow-up
3.186035
383
83.16199
1
male
1
3
3
Coma
Coma
1
null
null
89
13,767
7,227.2383
null
25
white
21.898438
29
0.148987
0.097992
1
0
0
no
null
null
dnr after sadm
2
93
18
150
32
37.89844
593
null
null
1.199951
136
7.439453
null
null
null
null
null
<2 mo. follow-up
3.277344
384
57.52798
0
male
0
20
1,722
Coma
Coma
0
null
null
94
82,244
39,760.5938
null
25.333328
white
16.5
19
0.529907
0.459961
1
0
0
no
0.1
0.001
no dnr
20
60
19.796875
75
15
36.89844
210
null
null
1
137
7.469727
null
null
null
null
null
null
2.398926
385
73.66498
1
male
0
7
31
Colon Cancer
Cancer
1
12
under $11k
0
9,640
6,026.8203
null
7
white
17.199219
22
0.797974
0.571899
1
0
0
metastatic
0.6
0.2
dnr after sadm
1
93
3.5
84
20
36.39844
null
null
null
1.5
133
null
null
null
null
null
3
<2 mo. follow-up
3
386
46.51099
0
male
0
74
1,717
Cirrhosis
COPD/CHF/Cirrhosis
1
15
$25-$50k
100
603,388
324,555
null
42
black
38.296875
83
0.054993
0.006
1
0
0
no
0.5
0.5
no dnr
74
67
17.597656
110
36
39
420
1.5
31.597656
5.5
137
7.629883
null
null
null
null
6
adl>=4 (>=5 if sur)
6
387
78.91895
1
female
1
37
37
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
55
219,537
104,714.062
null
35
white
22.199219
43
0.56189
0.449951
2
0
0
no
null
null
dnr after sadm
28
60
27.597656
100
18
38.5
282.8125
2.699707
null
2.599609
140
7.359375
null
null
null
null
null
<2 mo. follow-up
3.28418
388
68.91394
1
female
0
11
253
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
30,869
17,227.4375
null
15
white
25.199219
28
0.774902
0.701904
1
0
0
no
null
null
no dnr
11
67
16.097656
135
32
37.19531
222.84375
3.099609
0.599976
0.5
135
7.5
null
null
null
null
null
null
2.762207
389
42.29199
1
female
1
5
5
MOSF w/Malig
ARF/MOSF
2
null
null
0
161,776
84,674.25
null
53
white
57.59375
77
0.001
0
36
0
0
yes
null
null
dnr after sadm
4
42
14.298828
115
35
38.39844
32
null
1.699951
3.5
125
7.25
null
null
null
null
null
<2 mo. follow-up
2.140137
390
46.57898
1
male
0
7
316
CHF
COPD/CHF/Cirrhosis
1
22
under $11k
0
17,254
10,264.8203
null
12
black
19.398438
23
0.909912
0.848999
1
0
0
no
null
null
no dnr
7
72
6.299805
100
20
36.19531
null
null
null
1.599854
136
null
null
null
null
0
null
null
0.4948
391
54.03998
0
male
0
15
1,712
CHF
COPD/CHF/Cirrhosis
3
16
>$50k
0
135,849
92,919.4375
null
22.666656
white
25.597656
26
0.830933
0.724976
1
0
0
no
null
null
no dnr
15
68
5.299805
110
12
36.09375
353.3125
3.099609
1.799805
1.199951
129
7.529297
null
null
null
0
1
null
1
392
45.10599
0
male
0
8
1,711
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
35,204
18,938.3125
null
19.5
white
25.699219
33
0.845947
0.792969
1
0
0
no
null
null
no dnr
8
92
8
120
36
37.09375
142.84375
2.899902
null
1.299805
134
7.5
null
null
null
null
null
null
2.760254
393
87.46295
1
female
0
10
1,503
CHF
COPD/CHF/Cirrhosis
1
null
>$50k
0
12,163
7,719.5469
null
6.5
white
20.398438
21
0.775879
0.642944
1
0
0
no
0.95
0.8
no dnr
10
93
8.398438
84
20
36.39844
342.8125
null
null
0.799927
126
7.489258
null
null
null
null
null
no(M2 and SIP pres)
3.779297
394
79.24695
1
female
1
34
34
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
26
174,898
83,313.125
null
32.5
black
26.699219
51
0.55896
0.445984
3
0
0
no
null
null
dnr after sadm
18
73
10.599609
110
25
37.59375
115
2.099609
null
1.099854
135
7.5
null
null
null
null
0
<2 mo. follow-up
0
395
39.73999
1
male
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
26
352,017
237,611.75
null
50
other
38.195313
75
0.441956
0.32196
12
0
0
no
null
null
no dnr
4
60
20.597656
130
44
39.29688
238
3.299805
11.099609
4.599609
146
7.429688
null
null
null
null
null
<2 mo. follow-up
3.224121
396
78.17395
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
41
372,459
185,530.625
null
45
asian
47.695313
82
0.007
0.001
48
0
0
no
null
null
dnr after sadm
5
45
10.5
120
28
36.89844
317.5
5.799805
23.199219
2.299805
131
7.439453
null
null
null
null
null
<2 mo. follow-up
2.979492
397
79.13196
1
female
0
13
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
36,811
19,305.6875
null
19
white
32.296875
39
0.362
0.243988
1
0
0
metastatic
null
null
no dnr
13
47
18.199219
90
22
37.19531
100
null
0.699951
0.899902
136
7.449219
null
null
null
null
null
<2 mo. follow-up
4.635742
398
70.63898
1
male
0
32
376
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
null
0
104,045
60,743.4688
null
14.5
white
27.597656
32
0.647949
0.547974
12
0
0
no
0.15
0.00337
no dnr
32
80
11.298828
95
18
37
148.3125
4.199219
0.699951
5.799805
139
7.229492
null
null
null
0
null
null
0.4948
399
41.26498
1
female
1
118
118
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
55
597,427
312,839.5
null
40
white
48
87
0.123993
0.054993
1
0
0
no
0.8
0.7
dnr after sadm
118
53
8.099609
129
26
36.5
92
4
11.699219
4.199219
151
7.319336
null
null
null
null
null
no(M2 and SIP pres)
3.331543
400
38.35699
1
female
0
5
303
Colon Cancer
Cancer
1
null
null
0
5,573
3,331.4453
null
12
white
19.199219
11
0.835938
0.640991
1
0
0
metastatic
null
null
no dnr
5
71
8.398438
80
16
36.79688
null
3
0.5
0.799927
139
null
null
null
null
null
null
null
2.004395